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Abstract
Introduction: Adipose tissue through the many secreted adipocytokines creates a highly active metabolic and endocrine organ. The evalu-
ation of serum adipocytokine concentration in children with chronic kidney disease (CKD) could serve as a marker of cardio-vascular 
complication progression and an index of outcome in adulthood and after kidney transplantation.
Material and methods: The aim of the study was to evaluate simultaneously the serum concentrations of six different adipocytokines: 
adiponectin, apelin, chemerin, omentin, resistin, and vaspin, in 28 children with CKD stage 5 on haemodialysis and peritoneal dialysis.
Results: The concentration of apelin, omentin, and resistin in children with CKD was significantly higher and the concentration of 
vaspin, adiponectin, and chemerin was significantly lower than in the control group. After adjusting to body mass index (BMI), the same 
results were obtained. After adjusting to body surface area (BSA), the concentration of vaspin, adiponectin, and chemerin did not differ 
between children with CKD and the control group. In analysis of the correlation between serum total adipocytokine levels in children 
with CKD we found a negative relationship in pairs: omentin–apelin and omentin–vaspin, and positive in pairs: adiponectin–chemerin 
and adiponectin–resistin.
Conclusions: Our results show that changes in serum adipocytokines concentration are associated with the kidney dysfunction in CKD 
in children. Longitudinal studies on larger groups of paediatric cohorts would be helpful in investigating whether adipocytokines play 
a harmful role in the development of CKD and would enable further understanding of the risk factors for CKD progression. 
(Endokrynol Pol 2015; 66 (2): 100–107)
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Streszczenie 
Wstęp: Tkanka tłuszczowa poprzez wydzielane liczne adipocytokiny tworzy narząd bardzo aktywny metabolicznie i hormonalnie. Ocena 
stężenia adipocytokin w surowicy krwi u dzieci z przewlekłą chorobą nerek (CKD) może służyć jako marker progresji powikłań sercowo-
-naczyniowych i wskaźnik rokowniczy w wieku dorosłym i po przeszczepie nerki. 
Materiał i metody: Celem pracy była ocena stężenia w surowicy krwi jednocześnie sześciu różnych adipocytokin: adiponektyny, apeliny, 
chemeryny, omentyny, rezystyny i waspiny u 28 dzieci z CKD w stadium 5. leczonych hemodializami i dializą otrzewnową. 
Wyniki: Stężenie apeliny, omentyny i rezystyny u dzieci z CKD było znacząco wyższe, stężenie waspiny adiponektyny, chemeryny było 
znacząco niższe niż w grupie kontrolnej. Po skorygowaniu do wartości BMI uzyskano takie same wyniki. Po skorygowaniu do wartości 
powierzchni ciała stężenia waspiny, adiponektyny i chemeryny nie różniły się u dzieci z CKD i w grupie kontrolnej. W analizie korelacji 
pomiędzy całkowitym stężeniem adipocytokin w surowicy krwi u dzieci z CKD stwierdzono ujemną zależność w parach: omentyna–
apelina i omentyna–waspina i pozytywną w parach: adiponektyna–chemeryna, rezystyna–adiponektyna.
Wnioski: Wyniki przedstawionego badania wskazują, że zmiany stężenia adipocytokin w surowicy krwi są związane z upośledzeniem 
czynności nerek w CKD u dzieci. Długoterminowe badania w większych grupach pediatrycznych byłyby pomocne w wyjaśnieniu, czy 
adipocytokiny odgrywają niekorzystną rolę w rozwoju CKD, oraz umożliwiłyby dalsze zrozumienie czynników ryzyka progresji CKD. 
(Endokrynol Pol 2015; 66 (2): 100–107)
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with the increased concentration in visceral adipose 
tissue [16]. Chen et al., in studies on rats, found that 
omentin has vasodilatory properties via the activation 
of synthesis of endothelial nitric oxide [17]. They con-
cluded that omentin might play a role in blood pressure 
regulation, acting directly on blood vessel relaxation. 
Prats-Puig et al., in their study, were the first ones to 
show that circulating omentin-1 was associated with BP 
in childhood, which was independent of age, gender, 
and fat mass content [18].
Hida et al. [19] in 2005 identified a new adipocy-
tokine: visceral adipose tissue-derived serpin, which 
was given the name vaspin. It is believed that the 
increase in expression of vaspin in the adipose tissue 
may be a compensatory mechanism that occurs in re-
sponse to increasing obesity and insulin resistance [20]. 
The ability to block NADPH oxidase activity by vaspin, 
which was confirmed by Phalitakul et al., supports the 
hypothesis that vaspin may act as a protective factor 
against atherosclerosis [21]. The relationship between 
the vaspin concentration and renal dysfunction is not 
fully understood. Raised vaspin concentrations in pa-
tients with CKD may result from diminished elimina-
tion and persistent inflammatory condition. Seeger et 
al. showed higher vaspin levels in women with CKD 
on haemodialysis and in healthy female controls, inde-
pendently of age [20].
The next adipocytokine that accounts for a factor 
of CKD progression is resistin. In adult patients with 
CKD it was found that resistin has a proinflammatory 
effect and can enhance cardio-vascular abnormalities 
resulting from persistent inflammation [22]. Stępień 
et al. observed a negative correlation between serum 
resistin and eGFR, both in CKD and non-CKD patients, 
in their study of obese adult patients [23]. Nehus et al. 
examined serum resistin levels in children with chronic 
kidney disease and documented a negative correlation 
with GFR and a positive correlation with urine protein-
to-creatinine ratio. They also found positive association 
of pubertal status with serum resistin levels [1]. 
In the present study we evaluated simultane-
ously six different adipocytokines: adiponectin, apelin, 
chemerin, omentin, resistin and vaspin in children with 
CKD stage 5. To date, there are no available studies in 
children on such adipocytokine combinations, which 
includes both adipocytokines of a protective role in 
CKD (apelin, adiponectin, omentin, vaspin) and of 
a promoting role in CKD (resistin, chemerin).
Material and methods
The study group consisted of 28 children and young 
adults with CKD stage 5 and 20 healthy children. Gender, 
mean age, anthropometric data, blood pressure values, 
Introduction
It is well known that adipose tissue through secreted 
adipocytokines creates a complex and highly active 
metabolic and endocrine organ. Solely adipocytokines 
with their receptors could act in endocrine and par-
acrine mode expressing their abnormalities in obesity 
conditions and as well as in wasting disorders. The data 
on various adipocytokines concentrations and their role 
in children with chronic kidney disease (CKD) are not 
abundant. The evaluation of adipocytokines concentra-
tion in children with CKD is extremely important since 
it could serve as a marker for cardio-vascular complica-
tion progression and final outcome in adulthood and 
after kidney transplantation [1–4].
Adiponectin described almost 20 years ago is a unique 
adipocyte-derived hormone, which represents antidia-
betic, anti-inflammatory, and anti-atherogenic properties 
[5]. Mills et al. found that adult patients with higher adi-
ponectin levels have greater odds of CKD in their study 
on cohort of 201 patients [6]. They documented the simul-
taneous influence of older age, higher BMI value, gender, 
and cardiovascular events history on the likelihood of 
CKD in logistic regression analysis. Adiponectin also exerts 
renoprotective effects by albuminuria inhibition, which 
was documented in rodents [7].
Apelin, the next adipocytokine, plays a role in the 
regulation of cardiovascular, gastrointestinal, and im-
mune functions, and it has an influence on bone metab-
olism, fluid homeostasis, and intrauterine development 
of the cardiovascular system [8–10]. This hormone is 
expressed in different tissues; kidney and endothelial 
cells among them. Zhang et al. found that apelin in-
duced the proliferation of glomerular endothelial cells 
in a dose-dependent manner. They also described in-
creased permeability in diabetic glomeruli, which could 
be associated with a role of apelin in the pathogenesis 
of diabetic nephropathy [11]. Silva et al. found in their 
study that apelin levels showed a negative correlation 
with cardiovascular risk factors and positive correlation 
with estimated glomerular filtration rate (eGFR) [12].
Chemerin is one of the newly recognised adipocy-
tokines. It is proposed that chemerin is involved in the 
liver — adipose tissue — skeletal muscles system axis. 
Some data are also available showing that chemerin 
plays a role in the metabolism of carbohydrates and 
fats [13]. Hu et al. documented in their study in type 2 
diabetic rats that creatinine clearance and serum cre-
atinine remained significantly associated with serum 
chemerin [14]. Pfau et al. detected high circulating 
chemerin concentration in adult patients on haemodi-
alysis, independently of age and gender [15]. 
Omentin is the adipocytokine secreted by the stroma 
cells of adipose tissue, not by adipocytes themselves, 
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and laboratory test results are shown in Table I. In all 
children, Cole index, body mass index (BMI) (body 
weight [kg)]/height [m2]), and percentiles for BMI and 
body surface area (BSA) were calculated. The examined 
children and healthy controls were in Tanner stage 3–5, 
similarly in both groups.
The main causes of CKD were: tubulointerstitial 
nephritis (TIN) together with congenital defects of the 
urinary tract and/or recurrent infections (12 children 
— 42.9%) and polycystic kidney disease (5 children 
— 17.9%). Other causes were chronic glomerulone-
phritis (4 children — 14.3%), TIN accompanying mye-
lomeningocele (3 children — 10.7%), nephronophthisis 
(2 children — 7.1%), hypo-dysplasia of the kidneys 
(1 child — 3.6%), and neurofibromatosis (1 child — 3.6%). 
During the study and for the preceding month, children 
were in stable clinical condition without features of acute 
infection. All the children remained on pharmacotherapy 
of CKD (diuretics, renoprotection with ACE inhibitor, 
carbohydrate supplementation, antihypertensive agents, 
ferric and folate formulas). Twenty-seven children re-
ceived erythropoietin. 
Ten children were treated by haemodialysis. Dialysis 
was performed using Fresenius 2008 C and A (Fresenius 
Medical Care AG, Bad Homburg, Germany) machines. 
Bicarbonate buffered dialysis fluid was applied. Water 
for haemodialysis was prepared by reverse osmosis and 
bacteriologically tested according to European stand-
ards. The mean time of session was 4 hours (3.5–5.0 
hours). The velocity of dialysate flow was 500 ml per 
minute, and blood flow was 130180 mL per minute. Low 
molecular weight heparin was used for anticoagulation 
during haemodialysis sessions. 
For automated peritoneal dialysis — 18 children 
(APD) dialysis fluid and equipment of Baxter (Baxter 
International, Deerfield, Illinois, USA) and Fresenius 
(Fresenius Medical Care AG, Bad Homburg, Germany) 
was used in accordance with the applicable schedule 
and under adequate control. 
Children included into the control group attended 
the outpatient paediatric clinic for non-immunological, 
non-inflammatory health problems and needed venous 
puncture.
The present study was approved by the Ethics 
Committee of the Medical University of Silesia in Ka-
towice. Written informed consent was obtained from 
the children’s parents.
Laboratory assays
Blood samples for assays were collected in the fasting 
state between 0800 and 0930 h. After centrifugation at 
1000 × g for 15 minutes at 4°C, the serum samples 
were frozen at –20°C until analysed. The absorbance 
measurements for all samples were performed using 
a Quant Universal Microplate Spectrophotometer 
(BioTek Instruments Inc., Winooski, VT) determined 
on the basis of the standard curve made for a series of 
dilutions of the standards available in the kit. Acquired 
data were analysed using KC Junior Software (v.1.31.5, 
Bio-Tek Instruments,Winooski, VT, USA).
 — Serum apelin-12 concentration was determined 
using commercial human Apelin-12 enzyme im-
munoassay kit (Phoenix Pharmaceuticals Inc., 
Burlingame, CA) following the manufacturer ’s 
instructions. 
 — Serum resistin concentration was measured by 
enzyme-linked immunosorbent assay kit (Mediag-
nost, Reutlingen, Germany).
 — Serum adiponectin concentration was measured 
by enzyme-linked immunosorbent assay kit (Bio-
Vendor, LLC, USA). 
 — Serum omentin concentration was determined 
using the immunoenzymatic method with the ap-
plication of the Human Omentin-1 kit (BioVendor, 
Czech Republic). 
 — Serum concentrations of chemerin were deter-
mined using the immunoenzymatic method by 
the Human Chemerin kit (BioVendor, Czech 
Republic). 
 — Serum vaspin concentration was determined us-
ing the immunoenzymatic method by the Human 
Vaspin kit (BioVendor, Czech Republic). 
Table I. Characteristics of examined children
Tabela I. Charakterystyka badanych dzieci
Characteristics Children with CKD  
(n = 28)
Healthy Children  
(n = 20)
Age (years)
Sex (n)
Age at dialysis beginning 
(years)
Height [cm]
[percentile]
Weight [kg]
[percentile]
BMI [kg/m2]
[percentile]
Cole index
BSA [m2]
13.5 ± 5.5
F:16; M:12
11.5 ± 4.22
 
137.5 ± 24.6
7.5 ± 15.4 ‡
36.5 ± 15.7
17.5 ± 26.5 ‡
18.1 ± 3.3
40.9 ± 34.5
98.6 ± 17.9
1.17 ± 0.35
10.9 ± 4.4
F:12; M:8
–
 
144.9 ± 21.7
55.5 ± 30.0
39.5 ± 13.0
55.9 ± 26.8
18.3 ± 2.1
55.2 ± 31.2
104.0 ± 15.5
1.26 ± 0.3
Serum creatinine [μmol/L]
BUN [mmol/L]
Haemoglobin [g/dL]
Haematocrit (%)
696.5 ± 276.0 ‡
17.6 ± 6.8‡
10.3 ± 1.42‡
30.2 ± 4.23‡
50.11 ± 0.93
2.21 ± 0.4
13.4 ± 1.3
38.5 ± 4.2
BMI — body mass index; BSA — body surface area. Numeric data were shown 
as mean ± SD; ‡P < 0.0001 CKD vs. control
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Absolute values of each adipocytokine serum con-
centration were correlated with age, anthropometrical 
parameters (height, weight, BMI, Cole index), serum 
creatinine, BUN, haemoglobin concentration, haema-
tocrit, dialysis treatment duration, CKD duration, and 
systolic and diastolic blood pressure (BP sys and BP 
dia) values.
In the statistical analysis we used the Mann-Whitney 
U-test. Correlations were analysed with Pearson’s 
or Spearman tests, whichever was appropriate. The 
p values < 0.05 were considered significant.
Results
The mean age, absolute height, weight, BMI, BMI 
percentiles, Cole index, and BSA did not differ in 
comparison between children with CKD and healthy 
controls. Children with CKD had lower height and 
weight expressed in percentiles than healthy controls. 
The mean concentration of serum creatinine and BUN 
were significantly higher and the mean level of hae-
moglobin and Hct were lower in children with CKD, 
as compared to healthy children (Table I). In children 
with CKD the BP sys value was 112.4 ± 16.6 mm Hg 
and BP dia was 67.8 ± 13.9 mm Hg. The concentration 
of serum cholesterol and triglycerides was 4.79 ± 1.17 
mmol/L and 1.98 ± 1.4 mmol/L, respectively. In Table 
II the mean values of serum levels of adipocytokines 
in children with CKD and healthy children are shown. 
The concentration of apelin, omentin, and resistin was 
significantly higher and the concentration of vaspin, 
adiponectin, chemerin was significantly lower than 
in the control group. After adjusting to BMI value 
the same results of serum adipocytokine concentra-
tion were obtained in a comparison between children 
with CKD and healthy children. The application of 
adipocytokine/Cole index ratio gave the same results 
(data not shown). After adjusting to BSA value the 
concentration of vaspin, adiponectin, and chemerin 
did not differ between children with CKD and the 
control group.
In Table III the mean values of serum levels of 
adipocytokines in children with CKD regarding to 
gender and the type of renal replacement therapy are 
presented. There was only one significant difference 
in resistin concentration between boys and girls. The 
higher value of this adipocytokine we found in girls. 
There was no difference after adjustment of the adipo-
cytokine values to BMI or BSA. 
In Table IV we analysed the correlations between 
total adipocytokine serum levels and anthropometric, 
biochemical parameters listed in Table I (and, addition-
ally, blood pressure values in the CKD group) in the 
examined children. 
Significant correlations were not found regarding 
vaspin and omentin levels. In children with CKD the 
apelin concentration positively correlated with age, 
and the chemerin level showed negative correlation 
with height, weight, and BSA. In healthy children we 
documented a positive correlation of adiponectin level 
with height percentile, chemerin level with weight 
percentile and BMI, BMI percentile, Cole index, and 
negative correlation of resistin concentration with 
serum Hb concentration. 
In analysis of the correlation between serum total 
adipocytokine levels in children with CKD we found 
a negative relationship in the following pairs: omentin–
apelin and omentin–vaspin, and positive in: adiponec-
tin–chemerin and adiponectin–resistin. After adjusting 
to BMI, positive correlations were noted between all 
examined adipocytokines (Table V).
Table II. Mean values of adipocytokine serum levels in 
children with chronic kidney disease and healthy children
Tabela II. Średnie stężenie adipocytokin w surowicy krwi 
u dzieci z przewlekłą chorobą nerek i u dzieci zdrowych
Mean Adipocytokine 
Serum Levels
Children with CKD  
(n = 28)
Healthy Children  
(n = 20)
Apelin [pg/mL]
All subjects
Apelin/BMI
Apelin/BSA 
99.0 ± 8.0
5.6 ± 1.1
94.4 ± 36.3
82.1 ± 11.2*
4.5 ± 0.7*
69.2 ± 19.2#
Vaspin [ng/mL]
All subjects 
Vaspin/BMI
Vaspin/BSA
1.83 ± 0.26
0.10 ± 0.02
1.78 ± 0.83
2.3 ± 0.21*
0.13 ± 0.02*
2.0 ± 0.5
Adiponectin [ng/mL]
All subjects 
Adiponectin/BMI
Adiponectin/BSA
11.9 ± 1.4
0.68 ± 0.16
11.6 ± 5.4
15.2 ± 2.2*
1.8 ± 0.13*
12.7 ± 3.1
Omentin [ng/mL]
All subjects 
Omentin/BMI
Omentin/BSA
46.2 ± 3.7
2.6 ± 0.5
44.3 ± 17.6
31.7 ± 3.0*
1.8 ± 0.3*
26.8 ± 7.5*
Chemerin [ng/mL]
All subjects 
Chemerin/BMI
Chemerin/BSA
127.8 ± 16.4
7.3 ± 1.8
125.8 ± 65.3
184.0 ± 15.2*
10.1 ± 1.0*
154.7 ± 38.6
Resistin [ng/L]
All Subjects
Resistin/BMI
Resistin/BSA
14.4 ± 1.4
0.8 ± 0.2
14.0 ± 6.1
5.5 ± 0.9*
0.3 ± 0.1*
4.7 ± 1.45*
Data are shown as mean ± standard deviation. *P < 0.0001 CKD vs. control, 
#P < 0.006 CKD vs. control
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Discussion
Adipose tissue could have a harmful or beneficial in-
fluence depending on its content in the body. In CKD 
various adipocytokines could play a role enhancing 
endothelial dysfunction, oxidative stress, inflamma-
tion, atherosclerosis, kidney sympathetic activity, blood 
pressure, and anaemia [24, 25]. Alam et al. revealed 
that elevated adiponectin concentration is linked to 
higher risk for death in adult CKD patients after kidney 
transplantation [26]. However, they did not document 
the higher rate of allograft failure in these patients. 
Niemczyk et al. reported that adipocytokine levels in 
CKD are in most cases elevated, which is associated with 
their impaired excretion [20]. Contrary to the study by 
Kamariski et al. [2], we have shown lower adiponectin 
levels and adiponectin levels adjusted to BMI or Cole 
index in children with CKD, independently of renal 
replacement therapy PD or HD. There was also no 
correlation of adiponectin level with anthropometrical 
parameters in this group, but we demonstrated positive 
correlation with height percentile in healthy controls. 
Adiponectin deficiency is an independent risk factor 
for endothelial dysfunction, arterial hypertension, 
coronary heart disease, and other cardiovascular com-
plications [28]. So our observation on low adiponectin 
level in children with CKD could confirm that the pro-
tective influence of this adipocytokine was lost despite 
the existing positive correlation of adiponectin with 
chemerin and resistin, which promote atherosclerosis. 
As adiponectin in the Kamariski et al. study was directly 
correlated with age, the higher levels of this adipocy-
Table III. Mean values of adipocytokine serum levels in children with chronic kidney disease according to gender and the 
type of renal replacement therapy
Tabela III. Średnie stężenie adipocytokin w surowicy krwi u dzieci z przewlekłą chorobą nerek w zależności od płci i od 
rodzaju leczenia nerkozastępczego
Mean Adipocytokine Serum Levels Children with CKD
Boys Girls Haemodialysis Peritoneal Dialysis
Apelin [pg/mL]
All subjects
Apelin/BMI
Apelin/BSA 
99.4 ± 10.1
5.6 ± 1.1
92.2 ± 41.9
98.6 ± 6.4
5.7 ± 1.2
96.1 ± 32.8
98.7 ± 6.5
5.2 ± 0.8
77.3 ± 19.4
100.3 ± 7.6
5.9 ± 1.1
104.6 ± 42.6
Vaspin [ng/mL]
All subjects 
Vaspin/BMI
Vaspin/BSA
1.85 ± 0.2
0.09 ± 0.01
1.7 ± 0.9
1.8 ± 0.3
0.10 ± 0.03
1.8 ± 0.8
1.9 ± 0.2
0.10 ± 0.02
1.5 ± 0.3
1.8 ± 0.3
0.11 ± 0.03
1.9 ± 1.0
Adiponectin [ng/mL]
All subjects 
Adiponectin/BMI
Adiponectin/BSA
11.9 ± 1.4
0.68 ± 0.16
11.6 ± 5.4
12.2 ± 1.3
0.7 ± 0.2
11.6 ± 5.4
12.0 ± 2.0
0.64 ± 0.15
9.4 ± 2.5
12.0 ± 1.0
0.7 ± 0.2
12.9 ± 6.4
Omentin [ng/mL]
All subjects 
Omentin/BMI
Omentin/BSA
46.2 ± 3.7
2.5 ± 0.4
43.2 ± 20.5
46.2 ± 3.7
2.7 ± 0.6
45.0 ± 15.8
45.8 ± 3.3
2.4 ± 0.3
35.6 ± 5.3
46.1 ± 3.9
2.7 ± 0.6
48.4 ± 20.6
Chemerin [ng/mL]
All subjects 
Chemerin/BMI
Chemerin/BSA
127.8 ± 16.4
7.3 ± 1.8
125.8 ± 86.5
128.5 ± 17.8
7.5 ± 1.9
125.9 ± 46.8
127.9 ± 16.0
6.8 ± 1.4
100.9 ± 26.6
127.2 ± 17.4
7.6 ± 2.0
138.5 ± 78.5
Resistin [ng/L]
All Subjects
Resistin/BMI
Resistin/BSA
13.7 ± 1.6*
0.8 ± 0.2
12.9 ± 6.8
14.9 ± 0.9
0.9 ± 0.2
14.7 ± 5.6
14.4 ± 2.1
0.76 ± 0.13
11.3 ± 2.1
14.6 ± 1.5
0.9 ± 0.2
15.5 ± 7.3
Data are shown as mean ± standard deviation. *P < 0.01 boys vs. girls
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tokine in adults may result also from advanced age, 
and not only GFR decline [2]. Kaynar et al. found that 
adiponectin and resistin levels were significantly posi-
tively correlated with the presence of protein-energy 
wasting in adult patients with CKD [29]. Elshamaa et 
al. found higher levels of adiponectin in HD children 
as compared to children on conservative therapy of 
CKD. They also documented that genetic variations 
in the adiponectin gene seemed to have an impact on 
circulating adiponectin levels in these children groups 
(single-nucleotide polymorphisms at position 276) [3]. 
Unfortunately we did not have the opportunity to 
perform genetic evaluation in our study group.
Apelin according to Mafra et al., it is also an os-
teoblastic factor, which is protective to bone in adult 
patients on haemodialysis, and its action is mediated by 
G-protein-coupled receptor with a theoretically oppo-
site effect to PTH receptor [30]. In children we detected 
higher levels of apelin irrespectively to dialysis method, 
with a positive correlation with age. This adipocytokine 
may promote growth, increasing its concentration with 
age. Additionally, its higher concentration could be the 
result of progression of endothelial dysfunction/inflam-
mation in CKD patients, as reported by Małyszko et al. 
[31]. It is also a valuable finding because the examined 
children with CKD had no superimposed co-morbidity 
as adult patients.
In recent investigations, high chemerin levels have 
also been shown to correlate with better survival in 
patients on haemodialysis (HD), and were a predictor 
of regional adiposity in HD patients [17]. Yamamoto 
et al. reported that, in incident patients on dialysis, 
elevated chemerin concentration is associated with bet-
ter survival, despite its significant positive association 
with markers of inflammation and dyslipidaemia [32].
To our knowledge, this is the first study on the 
serum chemerin concentrations in children suffering 
from CKD. Our study demonstrated significantly 
lower serum levels of chemerin in children with CKD 
in comparison to the concentrations of this hormone 
in healthy children, also after adjustment for BMI, but 
not after adjustment to BSA. We have not shown any 
positive correlation of chemerin level and BMI in chil-
dren with CKD. The negative correlation of chemerin 
concentration and weight in this group supports the 
hypothesis that low levels of the hormone might result 
from the loss of the body mass, caused by nutritional 
restrictions or poor appetite in children with CKD or 
low-grade inflammatory processes. 
Possibly the increased production and/or release 
of adipose tissue hormones, such as omentin into 
the blood, enhancing insulin sensitivity, is one of the 
mechanisms of the adaptation to the state of malnutri-
tion. Similar relationships have been demonstrated 
in girls with anorexia nervosa [Ziora — unpublished 
data]. Shang et al. believe that the concentration of 
serum omentin may be a potential biomarker for the 
development and progression of atherosclerosis in the 
coronary arteries in people with metabolic syndrome 
[33]. Omentin circulating in the blood can be considered 
as a useful biomarker of vascular endothelium function 
and proper synthesis of nitric oxide [34]. Higher levels of 
omentin in children with CKD, regardless of treatment 
modality, point to its beneficial effect in protecting arter-
ies. Alcelik et al. found also elevated levels of omentin 
in adult patients with CKD on haemodialysis [35].
Seeger et al. found that circulating vaspin is nega-
tively correlated with GFR but they did not document the 
difference between vaspin levels of patients on HD and 
healthy controls [20]. The connection between circulating 
levels of vaspin and components of the renal function 
in children has not been determined yet. In our study 
we found lower levels of total vaspin in children with 
CKD, as compared to the healthy group, without any 
difference between children on HD or PD. The difference 
was also seen after adjusting the vaspin level to BMI, 
but not after adjusting to BSA. There was no correlation 
with anthropometric or biochemical parameters. Inoue 
et al. examined adult haemodialysis patients and also 
found lower vaspin levels in this group. Vaspin protects 
vascular endothelial cells from apoptosis induced by 
free fatty acids, which may suggest the beneficial anti-
atherosclerotic effect of this adipocytokine [36].
Table IV. Analysis of correlation between total adipocytokine 
serum levels and anthropometric, biochemical parameters 
and blood pressure values in children with chronic kidney 
disease (Spearman)
Tabela IV. Analiza korelacji pomiędzy całkowitym stęże­
niem adipocytokin w surowicy krwi a parametrami 
antropometrycznymi, biochemicznymi i wartością ciśnienia 
tętniczego u dzieci z przewlekłą chorobą nerek
CKD Control
Apelin Age r = 0.4139,  
p < 0.03 
No correlation
Vaspin No correlation No correlation
Adiponectin No correlation Height percentile  
r = 0.4779, p < 0.04
Omentin No correlation No correlation
Chemerin Height r = –0.4394,  
p < 0.02
BMI r = 0.5365,  
p < 0.02
  Weight 
r = –0.4676, p < 0.02
BMI percentile  
r = 0.5015, p < 0.03
BSA 
r = –0.4656, p < 0.01
Weight percentile  
r = 0.4804, p < 0.04
Cole index r = 0.5213, p < 0.02
Resistin No correlation Hb r = –0.5324, p < 0.02 
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Mills et al. examined resistin levels in patients with 
CKD and found that higher resistin concentration 
was independently associated with lower eGFR and 
higher urinary albumin excretion [6]. Also, in children 
with CKD we confirmed higher absolute resistin level 
and level adjusted to BMI, and a negative correlation 
with haemoglobin concentration was revealed, which 
underlines the relationship of this adipocytokine with 
the severity of CKD. Similar conclusions were drawn 
by Maggio et al., who found that normal resistin levels 
result from both adequate nutritional state and con-
trolled inflammatory state in children with CKD [4].
Our study has limitations that should be considered. 
The examined group was rather small as the paediat-
ric population of children with CKD in stage 5 is not 
numerous, which reduced the power of the study. 
The causes of CKD showed also wide variability; how-
ever, children had no currently active immunological 
disease. All the children with CKD received various 
pharmacological treatments and remained on a low 
phosphate, low/normal protein diet, which could have 
an influence on serum adipocytokine concentration. 
A serious difficulty in our study was to establish the 
control group. Children with CKD are usually physi-
cally poorly developed with delayed puberty in com-
parison to their healthy counterparts. So we decided 
to perform additional relative adjustments of obtained 
serum adipocytokine values to BMI, BSA, and Cole 
index, which were similar in both groups of children. 
We did not collect data on body composition (e.g. based 
on bio-impedance), which could have provided a better 
tool for adipocytokine concentration adjustment before 
comparisons than basic anthropometric parameters. 
The attempt to determine if changed levels of adipo-
cytokines are a causative factor in CKD progression or 
just reflect the modification in their own metabolism, is 
also of limited value if based on cross-sectional study. 
This study also has several strengths, including the 
standardised methods of obtaining clinical and labora-
tory data and the unique simultaneous evaluation of 
six different adipocytokines. The time of CKD duration 
in children is usually shorter than in adult patients. In 
our studied group of children there were no age-related 
comorbidities such as diabetes or coronary artery is-
chaemic disease.
Conslusions
Our results show that serum adipocytokines are as-
sociated with renal impairment in CKD. Longitudinal 
studies carried out in larger paediatric cohorts would 
be helpful in investigation if adipocytokines play 
a harmful role in the development of CKD, and would 
enable further understanding of risk factors for CKD 
progression or its complications (e.g. cardiovascular 
disease).
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